MEDECAN SERVICES LIMITED
Company number 16863725 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: MEDECAN SERVICES LIMITED
Company reference: 16863725
Status: Active (Private Limited Company)
Incorporated: 18 November 2025
Sector: General and specialist medical practice (SIC 86210, 86220)
1. Financial Health Score
Grade: Not yet assessable
A conventional A–F financial health score cannot be assigned at this stage. The company has no filed annual accounts, so there are no balance sheet, profit and loss, or cash flow figures to measure. Assigning a grade now would be the equivalent of giving a patient a clean bill of health without any examination—administrative records exist, but the financial vital signs have not yet been recorded. A score can only be produced once the first set of accounts is filed and analysed.
2. Key Vital Signs
The following indicators are the only “vitals” currently available from the public record. They are administrative and structural rather than financial, but they provide an early picture of the company’s condition.
| Vital Sign | Reading | Interpretation |
|---|---|---|
| Company age | Incorporated 18 November 2025 | A newly formed entity. Like a neonatal patient, there is no trading history or financial track record yet. |
| Accounts status | No accounts filed; first accounts due 18 August 2027 | No financial statements are available for analysis. The first filing will be the first diagnostic test of the company’s financial health. |
| Confirmation statement | Last made up 1 June 2026; next due 15 June 2027; not overdue | Administrative compliance is currently in good order. This is a positive sign, though it says nothing about profitability or solvency. |
| Company status | Active; not in liquidation, administration, or receivership | The company is registered and trading (or preparing to trade); there are no formal insolvency proceedings. |
| Ownership / control | Medecan Ltd (corporate entity) holds more than 75% of shares and voting rights | The company is a subsidiary under majority control of a corporate parent. This may provide access to group resources, but the parent’s own financial strength is not shown in this data. |
| Business activity | SIC 86210 General medical practice; SIC 86220 Specialists medical practice | The company operates in the healthcare sector, which can involve specific regulatory and funding considerations. |
| Officers | One current director | A single director is responsible for day-to-day management and compliance. |
Missing vital signs: Because no accounts have been filed, the following standard financial health metrics cannot yet be calculated: - Liquidity (can the company pay its bills as they fall due?) - Solvency (do assets exceed liabilities?) - Profitability (is the business generating surplus after costs?) - Working capital (is there enough cash tied up in day-to-day operations?)
3. Diagnosis
Condition: Early-stage entity with no published financial statements.
The available data shows a company that is administratively up to date but financially opaque. There are no “symptoms” of distress visible in the public record—no overdue filings, no insolvency proceedings, and no negative markers. However, the absence of accounts means there is also no evidence of financial strength. The company’s true condition—whether it is generating profit, burning cash, or carrying debt—cannot be diagnosed until the first accounts are filed.
In medical terms, this is a patient who has just registered with a practice: the registration paperwork is complete, but there is no medical history, no baseline blood pressure, and no cholesterol reading. The first accounts will serve as the initial health check.
4. Prognosis
Outlook: Guarded, pending first accounts.
The prognosis cannot be determined from current data. The company’s future financial health will depend on: - Whether it has commenced trading and at what scale; - The level of working capital and cash reserves it holds; - The extent of support, if any, received from its corporate parent, Medecan Ltd; - Its ability to meet the first accounts deadline of 18 August 2027.
If the first accounts reveal adequate cash reserves, positive net assets, and sustainable trading, the outlook can be revised positively. If they reveal losses, negative net assets, or liquidity pressures, early intervention will be needed.
5. Recommendations
-
Prepare and file the first accounts on time. The deadline is 18 August 2027. Late filing can incur penalties and creates a negative signal to creditors and suppliers.
-
Implement monthly management accounts. Even before the first statutory accounts are due, the company should track income, expenditure, and cash flow internally. This provides early warning of any financial strain.
-
Monitor cash position closely. For a new medical practice business, cash flow is often the most immediate pressure point. Ensure there is sufficient liquidity to cover staff, premises, and supplies.
-
Maintain confirmation statement compliance. The next confirmation statement is due 15 June 2027. Keeping this filing current avoids unnecessary penalties and keeps the public record accurate.
-
Clarify the relationship with the parent company. Understand whether Medecan Ltd provides funding, shared services, or guarantees, as this materially affects the company’s financial resilience.
-
Consider professional accounting support. Given the healthcare sector and the responsibilities of a limited company, engaging an accountant early can help ensure correct tax treatment, payroll compliance, and financial reporting.